Our Platform

What is CureiTec™?

 

CureiTec™ is Vaxx Research’s proprietary decentralized, AI-powered, blockchain-enabled specialized drug discovery and development platform. It is designed to accelerate the development of next-generation RNA vaccines, gene therapies, and cell-based treatments.  CureiTec™ integrates AI, machine learning, big data analysis and advanced bioinformatics to identify novel drug targets and mechanisms of action, optimize therapeutic designs, and streamline development for faster, safer and more effective solutions.

​

How CureiTec™ Works?

​

• AI-assisted discovery uses complex multivariate big data analysis, predictive modelling, large language model (LLM) and natural language processing (NLP) to identify safe and novel druggable targets.

 

• Blockchain-powered security ensures data & IP integrity and enables secure, transparent collaboration across research networks.

 

• Wet–lab validation integrates with real-world biological testing to refine AI predictions, ensure predictive AI validation, and enhance AI system accuracy.

 

• Scalable & Fast as it adapts quickly to existing platform-based enabling technologies, reducing drug discovery and development timelines by 50% or more and bringing breakthrough therapies to patients faster and more cost-efficiently.

 

Why CureiTec™ Matters?

 

It is designed collaboratively by clinicians, pharmaceutical scientists, biotechnologists, computer engineers and AI/ML experts to develop a practical, powerful, decentralized, cost-efficient AI solution to complement a specialized drug discovery and development platform.

 

• Speeds up genetic vaccines and cell & gene therapy drug development from discovery to clinical trials.

• Enables practical and affordable precision medicine solutions with AI-driven RNA & cell therapy solutions.

• Makes cutting-edge treatments more accessible & affordable.

​​

​​